A revolutionary NanoChannel technology for Genome mapping of extremely long DNA without amplification, providing long-range contiguity and eliminating PCR bias.
Accelerate to discover
Back to filter
Show all topics (10)
Related topics
Cytek LIVE Demo : introducing the new Autofluorescence (AF) Explorer in Spectroflo 3.2.1
Sep 25, 2023
In this webinar, Cytek will be covering the new features introduced in the newest SpectroFlo 3.2.1 software release and...
Educational webinar: Introducing MARS Platform for gentle cell separation
Sep 6, 2023
Join us for a webinar where we will introduce the new MARS Platform by Applied Cells, a...
Meet us in Prague this weekend (2.-5.9) at 12th International Conference of Analytical Cytometry
Aug 29, 2023
Meet ACCELA team at 12th International Conference of Analytical Cytometry 2.-5.9.2023 in Prague,
Aug 17, 2023
Register for an engaging webinar led by Naz Chaudary, Ph.D., and Research Technician, Alex Wang from the...
Optimizing Gene Expression with Bioluminescence & the piggyBac System
Aug 15, 2023
Discover how bioluminescence imaging & the piggyBac gene editing system optimize & track gene expression in mouse...
Cytek webinar: High Parameter Spectral Flow Cytometry for Tumor Immunology Research
Jul 28, 2023
High Parameter Spectral Flow Cytometry for Tumor Immunology Research: This webinar will be a guide for Designing,...
Webinar: Exploring Oncology applications with the WOLF G2 Cell Sorter and N1 Single-Cell Dispenser
Jun 19, 2023
This educational webinar invites you to explore the scientific capabilities and oncology applications of the...
Webinar recording: Multimodal tissue imaging and machine learning to advance precision medicine
Jun 2, 2023
Enjoy this recorded webinar to learn how the Orion spatial biology imaging platform was used to identify prognostic...
Next generation karyotyping: detecting cancer-associated structural variants using optical maps
Apr 19, 2017
James Broach, PhD, Penn State Hershey, Pennsylvania, United States.
Identification of structural variants (SVs) is critical to the prognosis of acute myeloid leukemia (AML) and other hematologic malignancies. SVs are not readily identified by next generation sequencing methods and are currently diagnosed by cytogenetics, an intrinsically low resolution tool. Dr. James Broach from Penn State Hershey will discuss a new method for determining large SVs as a clinical tool for evaluating AML and other cancer genomes using Bionano optical mapping. Dr. Broach has applied this technology for detection of SVs in a variety of cancer cell lines and directly from leukemia patient blood samples. In all cases, they have identified all the SVs reported by classic cytogenetic analysis and, in addition, a large number of translocations, deletions and insertions not observed by cytogenetics.
Get more info
Brand profile
